The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

MDR1  -  Mdr1p

Saccharomyces cerevisiae S288c

Synonyms: G5717, GTPase-activating protein GYP2, GYP2, MAC1-dependent regulator, MIC1, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

High impact information on MDR1

  • We further demonstrate that TRAPPII specifically functions in a Ypt31p-dependent pathway and identify Gyp2p as the first biologically relevant GTPase activating protein for Ypt31p [1].
  • Resistance of Candida albicans to azole antifungal drugs is mediated by two types of efflux pumps, encoded by the MDR1 gene and the CDR gene family [2].
  • The cis-acting elements in the MDR1 promoter responsible for induction by BEN were localized between -399 and -299 upstream of the start codon [2].
  • To monitor MDR1 expression under several conditions, the MDR1 promoter was fused to the Renilla reniformis luciferase reporter gene (RLUC) [2].
  • Many of the drugs used in this analysis induce the MDR1 promoter at concentrations that inhibit cell growth [2].
 

Biological context of MDR1

 

Associations of MDR1 with chemical compounds

  • The activity of BMS-207147 was minimally affected by overexpression of the gene encoding the efflux pump MDR1, but MIC increases were observed with changes in ERG11 and with overexpression of the CDR transporter gene [6].
  • To examine the molecular basis for these effects, we studied expression of ERG genes (encoding azole and terbinafine targets) and CDR/MDR1 genes (encoding multidrug transporters) in C. albicans cells treated with fluconazole or terbinafine with or without TSA [7].
  • Deletion constructs of the MDR1 promoter were used to analyze the basal transcription of the promoter and its responses to the toxic compound BEN and the oxidizing agent tert-butyl hydrogen peroxide (T-BHP) [2].
  • We propose that multiple stage-specific signals, which may include Pik1p/PtdIns(4)P, TRAPPII and Gyp2p, impinge upon Ypt31 signaling to regulate Golgi secretory function [1].
 

Other interactions of MDR1

  • Conversely, overexpression of Gyp2p in wild-type cells interferes with recycling of GFP-Snc1p, and the cells accumulate membrane structures as evidenced by electron microscopy [8].
  • Gyp2p-GFP is distributed throughout the cytoplasm and accumulates in punctate structures, which concentrate in an actin-dependent manner at sites of polarized growth [8].
  • A whole-cell-based assay using Saccharomyces cerevisiae strains that overexpress Candida albicans CDR1 and MDR1 efflux pumps has been employed to screen natural product extracts for reversal of fluconazole resistance [9].
  • Opposite roles of the F-box protein Rcy1p and the GTPase-activating protein Gyp2p during recycling of internalized proteins in yeast [8].
 

Analytical, diagnostic and therapeutic context of MDR1

  • Northern blot analyses revealed overexpression of the MDR1 gene in all isolates, which in some isolates was accompanied by elevated levels of CDR1/CDR2 and ERG11 expression [10].

References

  1. Synthetic genetic array analysis of the PtdIns 4-kinase Pik1p identifies components in a Golgi-specific Ypt31/rab-GTPase signaling pathway. Sciorra, V.A., Audhya, A., Parsons, A.B., Segev, N., Boone, C., Emr, S.D. Mol. Biol. Cell (2005) [Pubmed]
  2. Drug-induced regulation of the MDR1 promoter in Candida albicans. Harry, J.B., Oliver, B.G., Song, J.L., Silver, P.M., Little, J.T., Choiniere, J., White, T.C. Antimicrob. Agents Chemother. (2005) [Pubmed]
  3. Transcription initiation of genes associated with azole resistance in Candida albicans. Harry, J.B., Song, J.L., Lyons, C.N., White, T.C. Med. Mycol. (2002) [Pubmed]
  4. A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains. Kusch, H., Biswas, K., Schwanfelder, S., Engelmann, S., Rogers, P.D., Hecker, M., Morschhäuser, J. Mol. Genet. Genomics (2004) [Pubmed]
  5. Transcriptional Regulation of MDR1, Encoding a Drug Efflux Determinant, in Fluconazole-Resistant Candida albicans Strains through an Mcm1p Binding Site. Riggle, P.J., Kumamoto, C.A. Eukaryotic Cell (2006) [Pubmed]
  6. In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole. Fung-Tomc, J.C., White, T.C., Minassian, B., Huczko, E., Bonner, D.P. Diagn. Microbiol. Infect. Dis. (1999) [Pubmed]
  7. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. Smith, W.L., Edlind, T.D. Antimicrob. Agents Chemother. (2002) [Pubmed]
  8. Opposite roles of the F-box protein Rcy1p and the GTPase-activating protein Gyp2p during recycling of internalized proteins in yeast. Lafourcade, C., Galan, J.M., Peter, M. Genetics (2003) [Pubmed]
  9. Capisterones A and B, which Enhance Fluconazole Activity in Saccharomyces cerevisiae, from the Marine Green Alga Penicillus capitatus. Li, X.C., Jacob, M.R., Ding, Y., Agarwal, A.K., Smillie, T.J., Khan, S.I., Nagle, D.G., Ferreira, D., Clark, A.M. J. Nat. Prod. (2006) [Pubmed]
  10. Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis. Cernicka, J., Subik, J. Int. J. Antimicrob. Agents (2006) [Pubmed]
 
WikiGenes - Universities